July 28: The Earnings Gauntlet — Health Care and Consumers Seize the Baton as Energy Pauses and Memory Melts Down

Market Regime

The macro foundation remains Goldilocks — sticky CPI at 2.81%, unemployment at 4.2%, VIX at 17.05, and a positively steep yield curve at +36 bps — but the market's internal rotation accelerated dramatically today. Breadth was solid at 58% of stocks advancing, yet the S&P 500 barely budged (+0.24%) as sector leadership lurched away from last week's winners. The message: this is no longer a simple "Energy up, Tech down" rotation. It's a broader re-pricing of earnings visibility, and the market is handing out its verdict one quarterly report at a time.

Mega Forces

1. The Earnings Gauntlet separates winners from pretenders. Today was a case study in earnings-driven dispersion. Itron surged 26% on 8.4x volume after crushing estimates and raising guidance. Kiniksa jumped 25% on ARCALYST revenue up 55% YoY. IQV gained 14% on a clean beat. UL rose 9% after posting its strongest volume growth since 2010. Yet Amkor plunged 25%, Corning lost 12%, and Sterlite dropped 15% — all on earnings-related selling. The pattern is clear: in a market where forward P/E is reasonable (~20.6x) but Shiller P/E is at 40x, the burden of proof has shifted entirely onto current-quarter execution. Beats are richly rewarded; misses are ruthlessly punished.

2. The Memory crash isn't just cyclical — it's structural. Memory Chips fell another 9.6% today, bringing the 1-month decline to -32%. This was the worst-performing theme again, and the pain spread to adjacent areas: Semiconductor Packaging & Test (-13.9%), Semi Cap Equipment (-7.4%), and Power Semiconductors (-6.4%). The proximate trigger is the CXMT IPO — the Chinese memory maker began trading to a staggering $487 billion valuation — flooding the market with new supply at the exact moment when the DRAM cycle appears to be rolling over. But the deeper story, as BlackRock's Wei Li noted, is that "scarcity sellers" — the compute, memory, and energy providers — are being re-evaluated now that the AI capex boom's biggest customers "still aren't making money." The memory names that were the highest-beta AI plays (SNDK -48% in a month, DRAM ETF -28%) are now deleveraging violently.

3. Health Care is emerging as the stealth leader. The sector gained +0.65% on the day — modest, but against the backdrop of Tech and Energy selling off, it was the only large sector with consistent institutional-quality buying. CROs (Clinical Research Organizations) surged +6.5% on the day, led by IQV's +14% earnings pop. Large-cap pharma and medtech — TMO (+3.0%), AMGN (+4.5%), ABT (+2.7%), SYK (+2.9%) — all posted solid gains. This isn't just defensive rotation; it's earnings conviction. The sector offers a rare combination: visible revenue growth, low geopolitical exposure, and reasonable valuations (forward P/Es in the 13–21x range for major names). After weeks of being ignored while Energy and Semis dominated the narrative, Health Care is quietly building momentum.

4. The consumer is alive — and bifurcating. Consumer Staples (+2.1%) and Consumer Discretionary (+2.1%) both topped the sector leaderboard, but for very different reasons. Staples were led by KO (+5.0%, hitting an all-time high on earnings) and UL (+9.0%), which reported its best volume growth since 2010. Discretionary strength came from travel and experiences: BKNG (+6.7%), DASH (+6.0%), RCL (+5.7%). The takeaway: the trade-down narrative (ACI plunging 22% last week on weak guidance) is real, but it's coexisting with robust demand for premium travel and brand-name staples. The consumer isn't weak — she's selective.

What's Working

• Earnings conviction plays: Companies that beat and raised guidance (ITRI, KNSA, IQV, UL, FSUN) were rewarded with double-digit moves on heavy volume. The market is desperate for visibility and willing to pay up for it.
• Insurance brokers and HR services: AON (+3.8%), BRO-like names, and the HR & Benefits Administration theme (+5.2% on the day, +26% for the month) continue to ride the "soft landing" narrative — rising employment and steady rates are ideal for these businesses.
• Large-cap Health Care: The combination of earnings momentum (NVO, TMO, ABT, AMGN all green), reasonable valuations, and defensive appeal is attracting capital during the semiconductor unwind.
• Travel & experiences: BKNG, DASH, RCL, EXPE (+6.3%) all broke out today. The post-pandemic travel cycle still has legs, and these names are showing relative strength.

What's Failing

• Memory and semiconductor equipment: The CXMT IPO has crystallized fears of a memory glut, and the selloff is cascading into equipment and packaging names. These are not dip-buying opportunities yet — RSI readings in the 25–30 range suggest deeply oversold conditions that can persist.
• Energy (short-term): After a blistering month (+9.5% for the sector), every major energy name sold off today. Oil Refining & Marketing, up +33% for the month entering the session, declined -1.4%. This looks like healthy profit-taking, not a regime change — but the easy money has been made.
• Quantum and speculative tech: Quantum Computing (-5.1% today, -27% for the month), Industrial Energy Storage (-5.6% today, -32% for the month), and the ARK-type disruptive growth basket continue to bleed as rate-sensitive, profitless names fall out of favor.

Strategy

Today's session confirms that we are deep in an earnings-driven stock-picker's market. The macro is benign, but sector-level bets are whipsawing: Energy led for three weeks and reversed, Semis have been falling for a month and accelerated lower, and Health Care has quietly strung together consistent gains. The playbook: follow the earnings conviction. Focus on companies that just beat and raised — the market is giving them a multi-day tailwind. Avoid catching falling knives in Memory and semi equipment until the CXMT overhang clears and RSI readings stabilize. The stealth opportunity is large-cap Health Care, where earnings visibility, reasonable valuations, and the rotation out of over-owned semis could create a durable trend. And don't ignore the bifurcated consumer — the premium-travel and brand-name-staples names are telling you something that the ACI headline does not.